Personal information

No personal information available

Activities

Collapse all

Employment (1)

Xiamen Branch, Zhongshan Hospital, Fudan University: Xiamen, Fujian, CN

(Department of Hepatic Oncology)
Employment
Source: Self-asserted source
Guobin Chen

Works (4)

Hepatic Arterial Infusion Chemotherapy with Oxaliplatin Plus Raltitrexed as an Alternative Option in Advanced Hepatocellular Carcinoma Patients with Failure of, or Unsuitability for, Transarterial Chemoembolization

Medicina
2022-09 | Journal article | Author
DOI: 10.3390/medicina58101343
Contributors: yanfang wu; Susu Zheng; Zhenzhen Zhang; Guobin Chen; Xiaochun Chen; Tanghui Zheng; Xinkun Guo; Hong Chen; Meixia Wang; Xiaoying Xie et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Efficacy of Transarterial Chemoembolization Combined with Molecular Targeted Agents for Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis

Cancers
2022-07 | Journal article | Author
DOI: 10.3390/cancers14153710
Contributors: Zhenzhen Zhang; Yanfang Wu; Tanghui Zheng; Xiaochun Chen; Guobin Chen; Hong Chen; Xinkun Guo; Susu Zheng; Xiaoying Xie; Boheng Zhang
Source: check_circle
Multidisciplinary Digital Publishing Institute

Recurrence Outcome in Hepatocellular Carcinoma within Milan Criteria Undergoing Microwave Ablation with or without Transarterial Chemoembolization

Medicina
2022-07 | Journal article | Author
DOI: 10.3390/medicina58081016
Contributors: Guobin Chen; Hong Chen; Xing Huang; Sisi Cheng; Susu Zheng; Yanfang Wu; Tanghui Zheng; Xiaochun Chen; Xinkun Guo; Zhenzhen Zhang et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Prognostic Significance of Tumor Growth Rate (TGR) in Patients with Huge Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization

Current Oncology
2022-01 | Journal article | Author
DOI: 10.3390/curroncol29020038
Contributors: Guobin Chen; Xiaoying Xie; Meixia Wang; Xinkun Guo; Zhenzhen Zhang; Lan Zhang; Boheng Zhang
Source: check_circle
Multidisciplinary Digital Publishing Institute
How many people are using ORCID?